Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Biopsy-free prediction of prostate cancer aggressiveness using deep learning and radiology imaging

View ORCID ProfilePegah Khosravi, Maria Lysandrou, Mahmoud Eljalby, Matthew Brendel, Qianzi Li, Ehsan Kazemi, Josue Barnes, Pantelis Zisimopoulos, View ORCID ProfileAlexandros Sigaras, Camir Ricketts, Dimitri Meleshko, Andy Yat, Timothy D. McClure, Brian D. Robinson, Andrea Sboner, View ORCID ProfileOlivier Elemento, View ORCID ProfileBilal Chughtai, View ORCID ProfileIman Hajirasouliha
doi: https://doi.org/10.1101/2019.12.16.19015057
Pegah Khosravi
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pegah Khosravi
Maria Lysandrou
3University of Chicago, Chicago, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahmoud Eljalby
4Department of Urology, Weill Cornell Medicine of Cornell University, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Brendel
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qianzi Li
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
5Mathematics and Statistics department, Carleton College, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ehsan Kazemi
6Yale Institute for Network Science, Yale University, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josue Barnes
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pantelis Zisimopoulos
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandros Sigaras
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandros Sigaras
Camir Ricketts
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitri Meleshko
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Yat
7New York-Presbyterian Hospital, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy D. McClure
4Department of Urology, Weill Cornell Medicine of Cornell University, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian D. Robinson
8Department of Pathology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Sboner
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
8Department of Pathology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Elemento
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
9WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier Elemento
Bilal Chughtai
4Department of Urology, Weill Cornell Medicine of Cornell University, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bilal Chughtai
  • For correspondence: imh2003@med.cornell.edu bic9008@med.cornell.edu
Iman Hajirasouliha
1Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medicine of Cornell University, NY, USA
2Caryl and Israel Englander Institute for Precision Medicine, The Meyer Cancer Center, Weill Cornell Medicine, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iman Hajirasouliha
  • For correspondence: imh2003@med.cornell.edu bic9008@med.cornell.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Magnetic Resonance Imaging (MRI) is routinely used to visualize the prostate gland and manage prostate cancer. The Prostate Imaging Reporting And Data System (PI-RADS) is used to evaluate the clinical risk associated with a potential tumor. However the PI-RADS score is subjective and its assessment varies between physicians. As a result, a definite diagnosis of prostate cancer requires a biopsy to obtain tissue for pathologic analysis. A prostate biopsy is an invasive procedure and is associated with complications, including hematospermia, hematuria, and rectal bleeding.

We hypothesized that an Artificial Intelligence (AI) can be trained on prostate cases where both imaging and biopsy are available to distinguish aggressive prostate cancer from non-aggressive lesions using MRI imaging only, that is, without the need for a biopsy.

Our computational method, named AI-biopsy, can distinguish aggressive prostate cancer from non-aggressive disease with an AUC of 0.855 and a 79.02% accuracy. We used Class Activation Maps (CAM) to highlight which regions of MRI images are being used by our algorithm for classification, and found that AI-biopsy generally focuses on the same regions that trained uro-radiolosts focus on, with a few exceptions. In conclusion, AI-biopsy provides a data-driven and reproducible way to assess cancer aggressiveness from MRI images and a personalized strategy to reduce the number of unnecessary biopsies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported using start-up funds (Weill Cornell Medicine) to Iman Hajirasouliha

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The links to the publicly available data sets from TCIA are available below: The public data obtained from TCIA: https://www.cancerimagingarchive.net/ PROSTATEx https://wiki.cancerimagingarchive.net/display/Public/SPIE-AAPM-NCI+PROSTATEx+Challenges PROSTATE DIAGNOSIS https://wiki.cancerimagingarchive.net/display/Public/PROSTATE-DIAGNOSIS PROSTATE MRI https://wiki.cancerimagingarchive.net/display/Public/PROSTATE-MRI

https://www.cancerimagingarchive.net/

https://wiki.cancerimagingarchive.net/display/Public/SPIE-AAPM-NCI+PROSTATEx+Challenges

https://wiki.cancerimagingarchive.net/display/Public/PROSTATE-DIAGNOSIS

https://wiki.cancerimagingarchive.net/display/Public/PROSTATE-MRI

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 19, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Biopsy-free prediction of prostate cancer aggressiveness using deep learning and radiology imaging
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Biopsy-free prediction of prostate cancer aggressiveness using deep learning and radiology imaging
Pegah Khosravi, Maria Lysandrou, Mahmoud Eljalby, Matthew Brendel, Qianzi Li, Ehsan Kazemi, Josue Barnes, Pantelis Zisimopoulos, Alexandros Sigaras, Camir Ricketts, Dimitri Meleshko, Andy Yat, Timothy D. McClure, Brian D. Robinson, Andrea Sboner, Olivier Elemento, Bilal Chughtai, Iman Hajirasouliha
medRxiv 2019.12.16.19015057; doi: https://doi.org/10.1101/2019.12.16.19015057
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Biopsy-free prediction of prostate cancer aggressiveness using deep learning and radiology imaging
Pegah Khosravi, Maria Lysandrou, Mahmoud Eljalby, Matthew Brendel, Qianzi Li, Ehsan Kazemi, Josue Barnes, Pantelis Zisimopoulos, Alexandros Sigaras, Camir Ricketts, Dimitri Meleshko, Andy Yat, Timothy D. McClure, Brian D. Robinson, Andrea Sboner, Olivier Elemento, Bilal Chughtai, Iman Hajirasouliha
medRxiv 2019.12.16.19015057; doi: https://doi.org/10.1101/2019.12.16.19015057

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (412)
  • Dentistry and Oral Medicine (69)
  • Dermatology (47)
  • Emergency Medicine (142)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4843)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (674)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (626)
  • Health Policy (318)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5326)
  • Intensive Care and Critical Care Medicine (328)
  • Medical Education (93)
  • Medical Ethics (25)
  • Nephrology (75)
  • Neurology (685)
  • Nursing (42)
  • Nutrition (114)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (205)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (778)
  • Public and Global Health (1810)
  • Radiology and Imaging (323)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)